MedTrace Logo

Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD.

NCT01944852 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2020-11-10

No results posted yet for this study

Summary

The DIDo study is an open-label, randomised, multicentre study with 2 parallel groups in incident CAPD patients aged of 65 at minimum :

* One group in which patients will receive 2 bags of icodextrin/day and 1 bag of glucose
* One group in which patients will receive 1 bag of icodextrin/day and 2 bags of glucose.

Conditions

  • Renal Insufficiency

Interventions

DRUG

Icodextrin

Sponsors & Collaborators

  • Pr Eric Goffin

    lead OTHER

Principal Investigators

  • Eric Goffin · UCL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2020-02-28
Completion
2020-02-28

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01944852 on ClinicalTrials.gov